{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:04:45Z","timestamp":1786982685114,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"DOI":"10.1007\/s13730-025-01036-8","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T02:34:50Z","timestamp":1766543690000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Successful hemodialysis initiation in acquired hemophilia a managed with susoctocog alfa and emicizumab"],"prefix":"10.1007","volume":"15","author":[{"given":"Ayano","family":"Kihara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0488-0098","authenticated-orcid":false,"given":"Masanori","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryohei","family":"Sumitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Okinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Miyakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumiyo","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taizo","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Minato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Wakino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"1036_CR1","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1182\/blood-2006-06-029850","volume":"109","author":"PW Collins","year":"2007","unstructured":"Collins PW, Hirsch S, Baglin TP, Dolan G, Hanley J, Makris M, et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors\u2019 Organisation. Blood. 2007;109:1870\u20137.","journal-title":"Blood"},{"key":"1036_CR2","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1080\/10245332.2017.1319115","volume":"22","author":"M Franchini","year":"2017","unstructured":"Franchini M, Vaglio S, Marano G, Mengoli C, Gentili S, Pupella S, et al. Acquired hemophilia A: a review of recent data and new therapeutic options. Hematology. 2017;22:514\u201320.","journal-title":"Hematology"},{"key":"1036_CR3","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.3324\/haematol.2019.230771","volume":"105","author":"A Tiede","year":"2020","unstructured":"Tiede A, Collins P, Knoebl P, Teitel J, Kessler C, Shima M, et al. International recommendations on the diagnosis and treatment of acquired hemophilia A. Haematologica. 2020;105:1791\u2013801.","journal-title":"Haematologica"},{"key":"1036_CR4","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2491\/jjsth.28.715","volume":"28","author":"Committee of Clinical Practice Guidelines for Acquired Hemophilia A","year":"2017","unstructured":"Committee of Clinical Practice Guidelines for Acquired Hemophilia A. Guidelines for the management of acquired hemophilia A: 2017 revision. Jpn J Thromb Hemost. 2017;28:715\u201347.","journal-title":"Jpn J Thromb Hemost"},{"key":"1036_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1182\/blood-2012-02-409185","volume":"120","author":"P Collins","year":"2012","unstructured":"Collins P, Baudo F, Knoebl P, L\u00e9vesque H, Nemes L, Pellegrini F, et al. Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). Blood. 2012;120:47\u201355.","journal-title":"Blood"},{"key":"1036_CR6","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/hae.12138","volume":"19","author":"JY Borg","year":"2013","unstructured":"Borg JY, Guillet B, Le Cam-Duchez V, Goudemand J, L\u00e9vesque H, SACHA Study Group. Outcome of acquired haemophilia in France: the prospective SACHA (Surveillance des Auto antiCorps au cours de l\u2019H\u00e9mophilie Acquise) registry. Haemophilia. 2013;19:564\u201370.","journal-title":"Haemophilia"},{"key":"1036_CR7","first-page":"279","volume":"136","author":"K Holstein","year":"2020","unstructured":"Holstein K, Liu X, Smith A, Kn\u00f6bl P, Klamroth R, Geisen U, et al. Bleeding and response to hemostatic therapy in acquired hemophilia A: results from the GTH-AH 01\/2010 study. Blood. 2020;136:279\u201387.","journal-title":"Blood"},{"key":"1036_CR8","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.4009\/jsdt.46.1089","volume":"46","author":"H Nogami","year":"2013","unstructured":"Nogami H, Hara T, Takeuchi N, Higashiyama C, Fujita T, Kawakami K, et al. A case of acquired hemophilia A treated by double-filtration plasmapheresis in a hemodialysis patient. Nihon Toseki Igakkai Zasshi. 2013;46:1089\u201394.","journal-title":"Nihon Toseki Igakkai Zasshi"},{"key":"1036_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.5414\/CN108854","volume":"87","author":"A Imafuku","year":"2017","unstructured":"Imafuku A, Sawa N, Ubara Y, Takaichi K. Acquired hemophilia A that developed during the induction of hemodialysis: the use of double-filtration plasmapheresis. Clin Nephrol. 2017;87:147\u201351.","journal-title":"Clin Nephrol"},{"key":"1036_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.4009\/jsdt.45.501","volume":"45","author":"M Yonemori","year":"2012","unstructured":"Yonemori M, Hayami H, Matsushita R, Oohashi T, Taniguchi K, Muta H, et al. A patient with acquired hemophilia A diagnosed during the induction period of hemodialysis: a case report. Nihon Toseki Igakkai Zasshi. 2012;45:501\u20135.","journal-title":"Nihon Toseki Igakkai Zasshi"},{"key":"1036_CR11","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1046\/j.1526-0968.1999.00208.x","volume":"3","author":"H Ogata","year":"1999","unstructured":"Ogata H, Sakai S, Koiwa F, Tayama H, Kinugasa E, Ideura T, et al. Plasma exchange for acquired hemophilia: a case report. Ther Apher. 1999;3:320\u20132.","journal-title":"Ther Apher"},{"key":"1036_CR12","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.4009\/jsdt.46.1007","volume":"46","author":"M Komatsu","year":"2013","unstructured":"Komatsu M, Awano K, Okazaki M, Tokiwa M, Tsuchiya K, Nitta K, et al. A case report: successful treatment of a patient with acquired hemophilia A using a combination of low-dose prednisolone and double filtration plasmapheresis. Nihon Toseki Igakkai Zasshi. 2013;46:1007\u201313.","journal-title":"Nihon Toseki Igakkai Zasshi"},{"key":"1036_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s13730-016-0229-y","volume":"5","author":"N Niwa","year":"2016","unstructured":"Niwa N, Yoshida T, Mizuno R, Oya M, Hayashi M. Renal hemorrhage caused by acquired inhibitors to coagulation factors VIII and V in a hemodialysis patient. CEN Case Rep. 2016;5:223\u20136.","journal-title":"CEN Case Rep"},{"key":"1036_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1046\/j.1526-0968.1999.00212.x","volume":"3","author":"N Narukawa","year":"1999","unstructured":"Narukawa N, Abe T, Shouno M, Kitabata Y, Okamoto M, Kobata H, et al. A case of factor VIII inhibitor-positive acquired hemophilia treated by plasmapheresis. Ther Apher. 1999;3:323\u20135.","journal-title":"Ther Apher"},{"key":"1036_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/hae.12627","volume":"21","author":"R Kruse-Jarres","year":"2015","unstructured":"Kruse-Jarres R, St-Louis J, Greist A, Shapiro A, Smith H, Chowdary P, et al. Efficacy and safety of OBI-1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia A. Haemophilia. 2015;21:162\u201370.","journal-title":"Haemophilia"},{"key":"1036_CR16","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1055\/a-2384-3585","volume":"125","author":"M Shima","year":"2025","unstructured":"Shima M, Suzuki N, Nishikii H, Amano K, Ogawa Y, Kobayashi R, et al. Final analysis results from the AGEHA study: emicizumab prophylaxis for acquired hemophilia A with or without immunosuppressive therapy. Thromb Haemost. 2025;125:449\u201359.","journal-title":"Thromb Haemost"},{"key":"1036_CR17","first-page":"498","volume":"13","author":"M Franchini","year":"2015","unstructured":"Franchini M, Castaman G, Coppola A, Santoro C, Zanon E, Di Minno G, et al. Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management. Blood Transfus. 2015;13:498\u2013513.","journal-title":"Blood Transfus"},{"key":"1036_CR18","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1365-2516.2005.01093.x","volume":"11","author":"M Sakai","year":"2005","unstructured":"Sakai M, Shima M, Shirahata A. Successful steroid pulse treatment in childhood acquired haemophilia with nephrotic syndrome. Haemophilia. 2005;11:285\u20139.","journal-title":"Haemophilia"},{"key":"1036_CR19","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1097\/MS9.0000000000000353","volume":"85","author":"M Alsultan","year":"2023","unstructured":"Alsultan M, Jomaa H, Shukri A, Hajij F, Hassan Q. Cyclosporine treatment for steroid-resistant nephrosis complicated with acquired hemophilia A: a case report. Ann Med Surg. 2023;85:1848\u201351.","journal-title":"Ann Med Surg"},{"key":"1036_CR20","first-page":"514","volume":"48","author":"H Shimizu","year":"2007","unstructured":"Shimizu H, Saitoh T, Osaki Y, Yamane A, Gohda F, Irisawa H, et al. Acquired hemophilia A developed at relapse of minimal change nephrotic syndrome. Jpn J Clin Hematol. 2007;48:514\u20137.","journal-title":"Jpn J Clin Hematol"},{"key":"1036_CR21","volume":"2018","author":"T Yamaguchi","year":"2018","unstructured":"Yamaguchi T, Kudo N, Endo S, Usui T, Imashuku S. Management of acquired hemophilia A in elderly patients. Case Rep Hematol. 2018;2018:6757345.","journal-title":"Case Rep Hematol"},{"key":"1036_CR22","doi-asserted-by":"publisher","first-page":"302","DOI":"10.5761\/atcs.cr.20-00257","volume":"28","author":"T Sakai","year":"2022","unstructured":"Sakai T, Azuma Y, Sano A, Sadamoto S, Tochigi N, Nagase D, et al. Perioperative bypassing agent therapy for pulmonary pleomorphic carcinoma with acquired hemophilia. Ann Thorac Cardiovasc Surg. 2022;28:302\u20136.","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"1036_CR23","volume":"13","author":"JL Miatech","year":"2021","unstructured":"Miatech JL, Kantamani D, Stagg MP. Management of acquired factor VIII inhibitors with NovoSeven and Obizur. Cureus. 2021;13:e19145.","journal-title":"Cureus"},{"key":"1036_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bvth.2024.100027","volume":"1","author":"D Kishi","year":"2024","unstructured":"Kishi D, Nishikubo M, Shimomura Y, Ishikawa T, Kondo T. Clinical characteristics and outcomes of acquired hemophilia A before and after emicizumab approval in Japan. Blood Vessels, Thrombosis Hemostasis. 2024;1:100027.","journal-title":"Blood Vessels, Thrombosis Hemostasis"},{"key":"1036_CR25","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1016\/j.jtha.2024.06.010","volume":"22","author":"C Hart","year":"2024","unstructured":"Hart C, Klamroth R, Sachs UJ, Greil R, Knoebl P, Oldenburg J, et al. Emicizumab versus immunosuppressive therapy for the management of acquired hemophilia A. J Thromb Haemost. 2024;22:2692\u2013701.","journal-title":"J Thromb Haemost"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-025-01036-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-025-01036-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-025-01036-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T02:34:52Z","timestamp":1766543692000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-025-01036-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["1036"],"URL":"https:\/\/doi.org\/10.1007\/s13730-025-01036-8","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors state that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the patient described in this case report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"7"}}